FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2946585494> ?p ?o ?g. }

• W2946585494 endingPage "494" @default.
• W2946585494 startingPage "482" @default.
• W2946585494 abstract "Extracellular vesicles (EVs) are phospholipid and protein constructs which are continuously secreted by cells in the form of smaller (30-200 nm) and larger (micron size) particles. While all of these vesicles are called as EVs, the smaller size are normally called as exosomes. Small EVs (sEVs) have now been explored as a potential candidate in therapeutics delivery owing to their endogenous functionality, intrinsic targeting property, and ability to cooperate with a host defense mechanism. Considering these potentials, we hypothesize that immune cell-derived sEVs can mimic immune cell to target cancer. However, different sEVs isolation technique reported poor yield and loss of functional properties. To solve this problem, herein we hybridized sEVs with synthetic liposome to engineer vesicles with size less than 200 nm to mimic the size of exosome and named as hybrid exosome (HE). To achieve this goal, sEVs from mouse macrophage was hybridized with synthetic liposome to engineer HE. The fluorescence-based experiment confirmed the successful hybridization process yielding HE with the size of 177 ± 21 nm. Major protein analysis from Blot techniques reveal the presence of EV marker proteins CD81, CD63, and CD9. Differential cellular interaction of HE was observed when treated with normal and cancerous cells thereby supporting our hypothesis. Moreover, a water-soluble doxorubicin was loaded in HE. Drug-loaded HE showed enhanced toxicity against cancer cells and pH-sensitive drug release in acidic condition, benefiting drug delivery to acidic cancer environment. These results suggest that the engineered HE would be an exciting platform for tumor-targeted drug delivery. STATEMENT OF SIGNIFICANCE: Extracellular vesicles (EVs) are phospholipid and protein constructs which are continuously secreted by cells in the human body. These vesicles can efficiently deliver their parental biomolecules to the recipient cells and assist in intracellular communication without a direct cell-to-cell contact. Moreover, they have the ability to perform some of the molecular task similar to that of its parent cells. For example, exosome derived from immune cells can seek for diseased and/or inflammatory cells by reading the cell surface proteins. However, different EVs isolation techniques reported poor yield and loss of functional properties. Therefore, to overcome this limitation, we herein propose to re-engineer immuno-exosome with a synthetic liposome as a refined biomimetic nanostructure for the delivery of doxorubicin (clinical drug) for breast cancer treatment." @default.
• W2946585494 created "2019-05-29" @default.
• W2946585494 creator A5012852135 @default.
• W2946585494 creator A5019632307 @default.
• W2946585494 creator A5031665612 @default.
• W2946585494 creator A5050797480 @default.
• W2946585494 date "2019-08-01" @default.
• W2946585494 modified "2023-10-17" @default.
• W2946585494 title "Macrophage-derived exosome-mimetic hybrid vesicles for tumor targeted drug delivery" @default.
• W2946585494 cites W174188130 @default.
• W2946585494 cites W1787140000 @default.
• W2946585494 cites W1965781173 @default.
• W2946585494 cites W1967700176 @default.
• W2946585494 cites W1975815647 @default.
• W2946585494 cites W1977692564 @default.
• W2946585494 cites W1986321004 @default.
• W2946585494 cites W1996649087 @default.
• W2946585494 cites W2018398216 @default.
• W2946585494 cites W2027342684 @default.
• W2946585494 cites W2057713753 @default.
• W2946585494 cites W2060513744 @default.
• W2946585494 cites W2068997124 @default.
• W2946585494 cites W2076266324 @default.
• W2946585494 cites W2082691117 @default.
• W2946585494 cites W2086518820 @default.
• W2946585494 cites W2088946184 @default.
• W2946585494 cites W2091250479 @default.
• W2946585494 cites W2096854615 @default.
• W2946585494 cites W2111545764 @default.
• W2946585494 cites W2114235650 @default.
• W2946585494 cites W2115749410 @default.
• W2946585494 cites W2115963159 @default.
• W2946585494 cites W2131464730 @default.
• W2946585494 cites W2145479354 @default.
• W2946585494 cites W2155441983 @default.
• W2946585494 cites W2167056256 @default.
• W2946585494 cites W2176562642 @default.
• W2946585494 cites W2176918495 @default.
• W2946585494 cites W2189911506 @default.
• W2946585494 cites W2259481044 @default.
• W2946585494 cites W2275543474 @default.
• W2946585494 cites W2299887359 @default.
• W2946585494 cites W2310174902 @default.
• W2946585494 cites W2313467648 @default.
• W2946585494 cites W2323362455 @default.
• W2946585494 cites W2330004628 @default.
• W2946585494 cites W2346112581 @default.
• W2946585494 cites W2403293254 @default.
• W2946585494 cites W2406609064 @default.
• W2946585494 cites W2533813918 @default.
• W2946585494 cites W2542999988 @default.
• W2946585494 cites W2557549566 @default.
• W2946585494 cites W2563463196 @default.
• W2946585494 cites W2565271826 @default.
• W2946585494 cites W2589694509 @default.
• W2946585494 cites W2736233594 @default.
• W2946585494 cites W2755677304 @default.
• W2946585494 cites W2764044430 @default.
• W2946585494 cites W2768241957 @default.
• W2946585494 cites W2784013833 @default.
• W2946585494 cites W2793760887 @default.
• W2946585494 cites W2806509900 @default.
• W2946585494 cites W2807099646 @default.
• W2946585494 cites W2827777376 @default.
• W2946585494 cites W2893560612 @default.
• W2946585494 cites W2896759930 @default.
• W2946585494 cites W2898311361 @default.
• W2946585494 cites W2898766743 @default.
• W2946585494 cites W2900756811 @default.
• W2946585494 cites W2902918110 @default.
• W2946585494 cites W2933304441 @default.
• W2946585494 cites W2937014425 @default.
• W2946585494 cites W2984379854 @default.
• W2946585494 cites W654621879 @default.
• W2946585494 cites W947799404 @default.
• W2946585494 doi "https://doi.org/10.1016/j.actbio.2019.05.054" @default.
• W2946585494 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/31129363" @default.
• W2946585494 hasPublicationYear "2019" @default.
• W2946585494 type Work @default.
• W2946585494 sameAs 2946585494 @default.
• W2946585494 citedByCount "213" @default.
• W2946585494 countsByYear W29465854942019 @default.
• W2946585494 countsByYear W29465854942020 @default.
• W2946585494 countsByYear W29465854942021 @default.
• W2946585494 countsByYear W29465854942022 @default.
• W2946585494 countsByYear W29465854942023 @default.
• W2946585494 crossrefType "journal-article" @default.
• W2946585494 hasAuthorship W2946585494A5012852135 @default.
• W2946585494 hasAuthorship W2946585494A5019632307 @default.
• W2946585494 hasAuthorship W2946585494A5031665612 @default.
• W2946585494 hasAuthorship W2946585494A5050797480 @default.
• W2946585494 hasConcept C104317684 @default.
• W2946585494 hasConcept C121608353 @default.
• W2946585494 hasConcept C12554922 @default.
• W2946585494 hasConcept C126511603 @default.
• W2946585494 hasConcept C130316041 @default.
• W2946585494 hasConcept C145059251 @default.
• W2946585494 hasConcept C171250308 @default.

• next